**Core tip:** The prediction of postoperative complications is important for providing appropriate perioperative management. In the present study, the predictive values for postoperative complications after gastrectomy with systemic lymphadenectomy for gastric cancer were compared among candidate preoperative factors to identify a simple and sensitive marker. Our results indicated that the preoperative platelet-lymphocyte ratio is a simple and useful predictor for complications after curative gastrectomy in patients with gastric cancer.

INTRODUCTION
============

Gastrectomy with systemic lymphadenectomy is the mainstay of treatment for resectable gastric cancer (GC)\[[@B1],[@B2]\]. Despite advances in surgical techniques and devices, some patients who undergo the procedure experience clinically relevant postoperative complications, such as anastomotic leakage and intraabdominal abscess, leading to a protracted recovery period, delayed administration of adjuvant chemotherapy and impaired quality of life\[[@B3],[@B4]\]. Risk management is an increasingly important healthcare issue. Developing a prediction tool based exclusively on preoperatively determined factors to identify patients most at risk of postoperative complications enables surgeons to provide appropriate informed consent information and perioperative management, ultimately minimizing the medical cost burden\[[@B5],[@B6]\].

Increasing evidence indicates that multiple factors influence local infection control and the process of wound healing\[[@B7]\]. Accordingly, numerous reports on predictive factors for postoperative complications, including inflammatory, immunological, nutritional, coagulation and organ functional indicators, have been published\[[@B8]-[@B11]\]. However, limited information from cross-comparisons of these factors is available for patients who undergo a D2 gastrectomy for GC.

The aim of the present study was to compare the predictive values for postoperative complications after gastrectomy among candidate preoperative factors based on routinely obtained laboratory data. After the factor that demonstrated the highest predictive value was determined, the optimal cutoff value and its clinical significance were evaluated.

MATERIALS AND METHODS
=====================

Ethics
------

This study conforms to the ethical guidelines of the World Medical Association Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects, and written informed consent for surgery and the use of clinical data were obtained from all patients as required by the Institutional Review Board of Nagoya University.

Patients, surgical procedure and perioperative treatment
--------------------------------------------------------

A total of 1194 patients underwent a gastrectomy for GC at the Department of Gastroenterological Surgery, Nagoya University between 1999 and 2016. We retrospectively analyzed the data of 312 patients according to the following inclusion criteria: no preoperative treatment; clinical T2-4 (advanced) GC according to the TNM Classification of Malignant Tumours, 7^th^ Edition\[[@B12]\]; D2 gastrectomy (distal gastrectomy or total gastrectomy) performed according to the Japanese Gastric Cancer Treatment Guidelines\[[@B13]\]; no combined resection of other organs except for the spleen and gallbladder; R0 gastrectomy performed and sufficient data for analysis. The choice of the reconstruction method was at the surgeon's discretion. A first-generation cephem-based antibiotic was administered immediately before surgery and every 3 h during surgery. Oral intake was routinely started on postoperative day 1 if no obvious problems were found. Percutaneous drainage or the replacement of drainage tubes was performed when signs of inadequate drainage were noted by computed tomography or ultrasound scans. Clinically relevant postoperative complications were defined as those of grade II or higher according to the Clavien-Dindo classification\[[@B14]\].

Study parameters
----------------

Blood tests were routinely performed two days before surgery. Data were collected retrospectively from the medical records focusing on five categories: blood cell count, coagulation, nutrition, renal function and inflammation. The parameters investigated as candidate predictive factors for postoperative complications, which can be rapidly measured in every hospital, included the following: white blood cell count, neutrophil count, total lymphocyte count (TLC), hemoglobin concentration, platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen, total protein, albumin, cholinesterase, total cholesterol, urea nitrogen, creatinine and C-reactive protein (CRP). In addition, some simple indices were employed as candidate indicators: neutrophil-lymphocyte ratio (NLR = neutrophil count/TLC), platelet-neutrophil ratio (PNR = neutrophil count/platelet count × 100), platelet-lymphocyte ratio (PLR = TLC/platelet count × 100), Onodera's PNI (PNI = 10 × albumin g/dL + 0.005 × TLC/mm^3^), Glasgow prognostic score (GPS) and the modified GPS\[[@B7],[@B8],[@B15]\].

Subgroup analyses
-----------------

Subgroup analyses according to age, body mass index (BMI), operative procedure and clinical disease stage were performed to evaluate the correlations between the selected predictive factors and the incidence of clinically relevant postoperative complications.

Statistical analysis
--------------------

A receiver operating characteristic (ROC) curve analysis was employed to calculate the area under the curve (AUC) and the sensitivity and specificity of the indicated variables to predict postoperative complications. The optimal cutoff value was determined using the Youden index\[[@B16]\]. The qualitative χ^2^ test and quantitative Mann-Whitney test were used to compare the two groups. Multivariable analysis was performed to identify independent risk factors for postoperative complications using binomial logistic analysis, and variables with a value of *P* \< 0.05 were included as covariates in the final model. All statistical analyses were performed using JMP 10 software (SAS Institute Inc., NC, United States). A statistically significant difference was indicated by a *P*-value \< 0.05.

RESULTS
=======

Patient characteristics
-----------------------

The demographic and preoperative characteristics of the 312 patients are presented in Table [1](#T1){ref-type="table"}. The median age was 66 years, and the male-to female ratio was 233:79. With respect to preoperative staging, 98, 71, 69, 55, 14 and 5 patients were classified as clinical TNM stages IB, IIA, IIB, IIIA, IIIB and IIIC, respectively.

###### 

Demographic and preoperative clinical characteristics of 312 patients

  **Variables**                             **Number of patients**
  ----------------------------------------- ------------------------
  Age, median (range)                       66 (20-96)
  Sex                                       
  Male                                      233
  Female                                    79
  Diabetes mellitus                         
  Absent                                    273
  Present                                   39
  Cardiac comorbidities                     
  Absent                                    217
  Present                                   95
  Pulmonary comorbidities                   
  Absent                                    292
  Present                                   20
  Preoperative symptoms                     
  Absent                                    172
  Present                                   140
  Preoperative body mass index, mean ± SD   21.9 ± 3.2
  Tumor location                            
  Entire                                    8
  Upper third                               68
  Middle third                              120
  Lower third                               116
  Tumor size (mm)                           
  \< 50                                     176
  ≥ 50                                      136
  UICC cT factor                            
  cT1                                       0
  cT2                                       150
  cT3                                       95
  cT4                                       67
  UICC cN factor                            
  cN0                                       157
  cN1                                       93
  cN2                                       53
  cN3                                       9
  UICC clinical stage                       
  IB                                        98
  IIA                                       71
  IIB                                       69
  IIIA                                      55
  IIIB                                      14
  IIIC                                      5

UICC: Union for International Cancer Control.

Comparison of predictive values among the candidate parameters
--------------------------------------------------------------

In total, 66 patients (21.1%) had grade II or higher postoperative complications. In terms of the types of complications, the cumulative numbers of patients who experienced anastomotic leakage, leakage of pancreatic fluids, intraabdominal abscess and bowel obstruction were 20 (6.4%), 12 (3.8%), 19 (6.1%) and 6 (1.9%), respectively. When the AUC value, which indicates the power to predict postoperative complications, of the 21 parameters was analyzed, the PLR demonstrated the highest AUC value (0.639) (Figure [1A](#F1){ref-type="fig"}). This value was greater than the values of the PLR components TLC (AUC 0.563) and platelet count (AUC 0.615) (Figure [1B](#F1){ref-type="fig"}). The optimal cutoff value for predicting complications using the PLR was set at 0.71 (sensitivity = 70%, specificity = 56%) (Figure [1B](#F1){ref-type="fig"}). The AUC values of NLR, PNR, PNI and GPS were 0.566 (cutoff = 3.06), 0.574 (cutoff = 1.36), 0.608 (cutoff = 47.0) and 0.582 (cutoff = 1), respectively (Figure [1A](#F1){ref-type="fig"}).
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Predictive value of the PLR
---------------------------

The median PLR was 0.71 (range 0.23-3.97), which is identical to the proposed cutoff. Using the cutoff indicated by the ROC curve analysis, we further evaluated the clinical significance of the PLR. Patients were categorized into two groups, the high (*n* = 158) and low (*n* = 154) PLR groups, using a PLR cutoff of 0.71. Compared to the high PLR group, patients in the low PLR group were associated with increased prevalence of pulmonary comorbidities, larger macroscopic tumor size and more frequent postoperative complications (Table [2](#T2){ref-type="table"}). However, no significant differences were observed between the two groups regarding age, sex, preoperative BMI, clinical stage, type of gastrectomy, operative time, intraoperative blood loss and number of dissected lymph nodes (Table [2](#T2){ref-type="table"}). In the univariate analysis, the odds ratio of a low PLR for postoperative complications was 2.94 (95%CI: 1.66-5.35, *P* \< 0.001; Table [3](#T3){ref-type="table"}). We next conducted a multivariable binomial logistic analysis involving other potential risk factors determined before surgery and found that a low PLR was an independent risk factor for postoperative complications (odds ratio 3.32, 95%CI: 1.82-6.25, *P* \< 0.001) along with male sex and total gastrectomy (Table [3](#T3){ref-type="table"}). With respect to the types of complications, the low PLR group exhibited an increased prevalence of anastomotic leakage, leakage of pancreatic fluids, intraabdominal abscess and bowel obstruction compared to the high PLR group. However, the differences were not statistically significant (Figure [2](#F2){ref-type="fig"}). By contrast, the incidence of cardiopulmonary dysfunction was comparable between the two groups.

###### 

Comparison between two subgroups according to the preoperative platelet-lymphocyte ratio

  **Variables**                               **PLR \< 0.71 (*n* = 154)**   **PLR** ≥ **0.71 (*n* = 158)**   ***P* value**
  ------------------------------------------- ----------------------------- -------------------------------- ---------------
  Age, median (range)                         66 (20-86)                    66 (34-96)                       0.661
  Sex                                                                                                        0.434
  Male                                        112                           121                              
  Female                                      42                            37                               
  Diabetes mellitus                                                                                          0.070
  Absent                                      140                           133                              
  Present                                     14                            25                               
  Cardiac comorbidities                                                                                      0.785
  Absent                                      106                           111                              
  Present                                     48                            47                               
  Pulmonary comorbidities                                                                                    0.021
  Absent                                      149                           143                              
  Present                                     5                             15                               
  Preoperative symptoms                                                                                      0.838
  Absent                                      84                            88                               
  Present                                     70                            70                               
  Preoperative body mass index, mean ± SD     21.6 ± 3.3                    22.2 ± 3.1                       0.102
  Tumor location                                                                                             0.673
  Entire                                      3                             5                                
  Upper third                                 32                            36                               
  Middle third                                57                            63                               
  Lower third                                 62                            54                               
  Tumor size (mm)                                                                                            0.043
  \< 50                                       78                            98                               
  ≥ 50                                        76                            60                               
  UICC cT factor                                                                                             0.502
  cT1                                         0                             0                                
  cT2                                         69                            81                               
  cT3                                         49                            46                               
  cT4                                         36                            31                               
  UICC cN factor                                                                                             0.633
  cN0                                         75                            82                               
  cN1                                         51                            42                               
  cN2                                         24                            29                               
  cN3                                         4                             5                                
  UICC clinical stage                                                                                        0.823
  IB                                          45                            53                               
  IIA                                         37                            34                               
  IIB                                         32                            37                               
  IIIA                                        31                            24                               
  IIIB                                        7                             7                                
  IIIC                                        2                             3                                
  Operative procedure                                                                                        0.669
  Total gastrectomy                           52                            57                               
  Distal gastrectomy                          102                           101                              
  Splenectomy                                                                                                0.191
  Absent                                      128                           122                              
  Present                                     26                            36                               
  Dissected lymph nodes, mean ± SD            37.6 ± 15.8                   38.7 ± 18.0                      0.823
  Operative time (min), mean ± SD             233 ± 56                      238 ± 74                         0.720
  Estimated blood loss (mL), median (range)   237 (1-2350)                  245 (8-4267)                     0.491
  Postoperative complications                                                                                \< 0.001
  Absent                                      108                           138                              
  Present                                     46                            20                               

PLR: Platelet-lymphocyte ratio; UICC: Union for International Cancer Control.

![Comparison of the prevalence of each complication type between the high and low platelet-lymphocyte ratio groups.](WJG-23-2519-g002){#F2}

###### 

Predictive factors for grade 2 or higher complications according to the Clavien-Dindo system: Univariate and multivariable analyses

  **Variables**                             **Univariate**   **Multivariable**                                 
  ----------------------------------------- ---------------- ------------------- ---------- ------ ----------- ----------
  Age (≥ 65 yr)                             1.26             0.73-2.23           0.410                         
  Gender (male)                             4.22             1.88-11.3           \< 0.001   4.17   1.78-11.5   \< 0.001
  Preoperative symptoms                     0.95             0.55-1.64           0.864                         
  Diabetes mellitus                         1.14             0.49-2.45           0.755                         
  Cardiac comorbidities                     1.81             1.02-3.18           0.041      1.55   0.83-2.87   0.166
  Pulmonary comorbidities                   1.26             0.40-3.40           0.669                         
  Body mass index (≥ 22)                    1.62             0.94-2.81           0.084                         
  Preoperative PLR (\< 0.71)                2.94             1.66-5.35           \< 0.001   3.32   1.82-6.25   \< 0.001
  Tumor location (lower third)              0.62             0.34-1.11           0.107                         
  Macroscopic tumor size (\> 50 mm)         1.19             0.69-2.05           0.534                         
  UICC cT (cT4)                             1.30             0.67-2.69           0.457                         
  UICC cN (cN1-3)                           1.75             1.01-3.08           0.045      1.69   0.93-3.08   0.083
  Operative procedure (total gastrectomy)   2.42             1.39-4.23           0.002      2.43   1.35-4.43   \< 0.001

Analyses were performed using binomial logistic analysis. PLR: Platelet-lymphocyte ratio; UICC: Union for International Cancer Control.

Subgroup analyses
-----------------

To further evaluate the clinical effect of the preoperative PLR on the postoperative course, subgroup analyses were conducted according to age (\< 65 years or ≥ 65 years), preoperative BMI (\< 22 or ≥ 22), operative procedure (distal or total gastrectomy) and clinical disease stage. The low PLR group exhibited an increased incidence of postoperative complications for all subgroup analyses (Figure [3](#F3){ref-type="fig"}).

![Subgroup analyses. The morbidity rates were compared between the high and low PLR groups according to age (A), body mass index (B), operative procedure (C) and clinical disease stage (D). Comparison of predictive value of potential indicators. PLR: Platelet-lymphocyte ratio.](WJG-23-2519-g003){#F3}

DISCUSSION
==========

The PLR, a combination of circulating platelet and lymphocyte counts, is a representative index of systemic inflammation and immune status\[[@B9],[@B17]\]. Accordingly, a decreased PLR value indicate both systemic inflammation and compromised immune reaction. Although preoperative systemic inflammation has been reported as an underlying characteristic that predisposes the host to postoperative infection, only limited evidence is available\[[@B18]\]. In this study, a significant relationship between the preoperative PLR and postoperative complications was demonstrated. The PLR exhibited the highest AUC value for the incidence of postoperative complications among the candidate parameters obtained from routine preoperative blood tests. A low preoperative PLR was identified as an independent risk factor for postoperative complications in the multivariable analysis. Moreover, a low preoperative PLR was associated with an increased incidence of postoperative complications independent of age, BMI, operative procedure and disease stage, indicating that the preoperative PLR is applicable to various clinical settings.

The PLR can be determined in every hospital and is the subject of interest as a marker of systemic inflammation in various clinical circumstances. Several reports indicate that the PLR can serve as a prognostic factor for digestive malignancies\[[@B9],[@B18]\]. Accumulating evidence indicates that a systemic inflammatory response could play an important role in the development and progression of cancer. Inflammation is closely related to different stages of tumor development, including initiation, invasion, metastasis, immune surveillance and responses to therapy\[[@B7],[@B8],[@B10],[@B19],[@B20]\]. However, the clinical impact of the preoperative PLR on postoperative short-term outcomes, particularly in patients undergoing a gastrectomy, remains unclear. Our results suggested that surgeons can provide precise informed consent information and identify high-risk patients to tailor perioperative care as an attempt to ultimately improve postoperative short-term outcomes for GC patients undergoing a gastrectomy using this prediction tool. Recently, preoperative risk calculation systems based on large-scale integrated databases, such as the Surgical Risk Preoperative Assessment System (SURPAS) and the Physiologic and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) model, have been widely used in clinical practice\[[@B5],[@B21]\]. Our data suggest that the PLR could at least become a potential constituent of integrated scoring systems for surgical risk assessment.

The association between a decreased PLR and the development of postoperative infectious complication is likely complex and remains unclear. One plausible explanation is that a decreased PLR may reflect four disadvantages for the postoperative course including an inflammatory status, immune disorders, malnutrition and a tendency for micro-vessel thrombosis\[[@B10],[@B18]\]. A decreased PLR collectively reflects a reduced TLC (compromised cell-mediated immunity and malnutrition) and an increased platelet count (inflammation and high thromphophilic diathesis). Lymphocytopenia is associated with malnutrition and cellular immunosuppression\[[@B22]-[@B24]\]. A pro-inflammatory status leads to compromised cell-mediated immunity and an impaired T-lymphocytic response *via* cytokines\[[@B25]\]. The ability of myeloid cells to synthesize pro-inflammatory and anti-inflammatory mediators is affected by their previous state\[[@B10],[@B18]\]. Malnutrition is a major cause of delayed wound healing\[[@B11],[@B15]\]. A decreased lymphocyte-mediated antibacterial immune reaction may weaken the lymphocyte-mediated antibacterial cellular immune response and contribute to increasing bacterial invasion and growth\[[@B10],[@B18]\]. The platelet count is recognized as a marker of a systemic inflammatory response and potential micro-vessel thrombosis\[[@B7],[@B9],[@B17]\]. Formation of micro-vessel thrombosis inhibits wound healing via the deterioration of blood circulation in tissues. Eventually, the crosstalk of these complex factors increases the incidence of postoperative complications. In addition, our findings raised two questions. First, why is the PLR was more sensitive than the other indices, such as the PNI and GPS? We hypothesize that the PLR is indicative of four elements, including inflammatory status, immune disorders, malnutrition and a tendency for micro-vessel thrombosis, and therefore it was more closely associated with postoperative complications than other indices. Another question is whether preoperative modification of the PLR by anti-inflammatory treatment and nutritional support reduces the adverse effects on the postoperative clinical course. Further investigations are needed to answer these questions.

The current study also had several limitations that should not be ignored. This was a retrospective study of a limited number of patients from a single institute. Thus, our findings require validation by further large-scale prospective studies. To further evaluate the association of the PLR with the host inflammatory and nutritional status, information on levels of cytokines and rapid turnover proteins is required.

Taken together, the results indicate that the preoperative PLR is a simple and useful predictor of postoperative complications in patients who undergo a gastrectomy with systemic lymphadenectomy for GC. In the future, the development of an integrated risk stratification system using the PLR may facilitate physicians' decision-making and contribute to the informed consent process before a gastrectomy.
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